The Caveolin-1 Binding Domain of HIV-1 Glycoprotein gp41 Is an Efficient B Cell Epitope Vaccine Candidate against Virus Infection
- 1 November 2004
- Vol. 21 (5) , 617-627
- https://doi.org/10.1016/j.immuni.2004.08.015
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Specificity and effect on apoptosis of Tat antibodies from vaccinated and SHIV-infected rhesus macaques and HIV-infected individualsVaccine, 2003
- Lipid rafts and HIV-1: from viral entry to assembly of progeny virionsJournal of Clinical Virology, 2001
- N- and C-domains of HIV-1 gp41: mutation, structure and functionsImmunology Letters, 2001
- Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug targetProceedings of the National Academy of Sciences, 1998
- Establishment of a Functional Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcription Complex Involves the CytoskeletonThe Journal of Experimental Medicine, 1998
- HIV-1 subtypes in Santiago, ChileAIDS, 1998
- Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical TrialsThe Journal of Infectious Diseases, 1997
- Core Structure of gp41 from the HIV Envelope GlycoproteinPublished by Elsevier ,1997
- Identification of Peptide and Protein Ligands for the Caveolin-scaffolding DomainJournal of Biological Chemistry, 1997
- Inhibition of HIV Infection by Pseudopeptides Blocking Viral Envelope Glycoprotein-Mediated Membrane Fusion and Cell DeathVirology, 1996